Durable Responses to Alectinib in Murine Models of EML4-ALK Lung Cancer Requires Adaptive Immunity

0
166
Investigators used three murine models of EML4-ALK lung cancer to test the role of host immunity in the alectinib therapeutic response.
[Npj Precision Oncology]
Full Article